Yifan Xinfu Pharmaceutical Co Ltd (002019) — Financial Flexibility Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥224.86 Million (operating CF CN¥40.18 Million minus capex CN¥184.68 Million) represents 0% of total liabilities (CN¥4.40 Billion). Check cash flow reinvestment rate of Yifan Xinfu Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 002019 cash flow metrics.
Annual Financial Flexibility Index for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Yifan Xinfu Pharmaceutical Co Ltd. Explore how well can Yifan Xinfu Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥1.02 Billion | CN¥458.37 Million | CN¥4.13 Billion | ▼ -25.1% |
| 2024 | 0.33x | CN¥1.27 Billion | CN¥640.73 Million | CN¥3.86 Billion | ▲ +25.1% |
| 2023 | 0.26x | CN¥852.67 Million | CN¥348.58 Million | CN¥3.24 Billion | ▼ -12.0% |
| 2022 | 0.30x | CN¥1.01 Billion | CN¥472.07 Million | CN¥3.40 Billion | ▲ +16.0% |
| 2021 | 0.26x | CN¥872.97 Million | CN¥301.23 Million | CN¥3.39 Billion | ▼ -57.8% |
| 2020 | 0.61x | CN¥1.82 Billion | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +9.8% |
| 2019 | 0.56x | CN¥1.80 Billion | CN¥937.24 Million | CN¥3.24 Billion | ▼ -15.5% |
| 2018 | 0.66x | CN¥1.90 Billion | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -19.3% |
| 2017 | 0.82x | CN¥1.62 Billion | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +119.8% |
| 2016 | 0.37x | CN¥1.14 Billion | CN¥855.85 Million | CN¥3.08 Billion | ▼ -0.2% |
| 2015 | 0.37x | CN¥619.11 Million | CN¥401.96 Million | CN¥1.67 Billion | ▲ +28.2% |
| 2014 | 0.29x | CN¥229.24 Million | CN¥139.74 Million | CN¥791.21 Million | ▼ -22.9% |
| 2013 | 0.38x | CN¥108.27 Million | CN¥34.32 Million | CN¥288.20 Million | ▲ +123.7% |
| 2012 | 0.17x | CN¥97.52 Million | CN¥29.88 Million | CN¥580.73 Million | ▲ +149.4% |
| 2011 | 0.07x | CN¥46.92 Million | CN¥-52.82 Million | CN¥696.73 Million | ▼ -79.7% |
| 2010 | 0.33x | CN¥165.50 Million | CN¥-33.82 Million | CN¥497.79 Million | ▼ -64.0% |
| 2009 | 0.92x | CN¥209.88 Million | CN¥58.61 Million | CN¥227.31 Million | ▲ +28.1% |
| 2008 | 0.72x | CN¥205.76 Million | CN¥83.31 Million | CN¥285.39 Million | ▼ -42.4% |
| 2007 | 1.25x | CN¥420.77 Million | CN¥248.71 Million | CN¥335.87 Million | ▲ +271.9% |
| 2006 | 0.34x | CN¥90.24 Million | CN¥32.62 Million | CN¥267.92 Million | ▼ -20.2% |
| 2005 | 0.42x | CN¥82.76 Million | CN¥24.12 Million | CN¥196.02 Million | ▼ -80.2% |
| 2004 | 2.13x | CN¥103.73 Million | CN¥33.59 Million | CN¥48.72 Million | ▲ +242.5% |
| 2003 | 0.62x | CN¥65.09 Million | CN¥12.65 Million | CN¥104.73 Million | — |